Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-27, Stock:PFE, The news for the past five days is as follows:
2018-12-19: NEWS1: Stocks Hit New Lows After Early Rally as Fed Hikes Key Rate.NEWS2: Health Care Sector Update for 12/19/2018: STRO,CELG,GSK,PFE,FGEN,SURF.NEWS3: Health Care Sector Update for 12/19/2018: STRO,CELG,GSK,PFE,FGEN,SURF.NEWS4: Glaxo Stock Pops On Pfizer Deal To Merge Consumer Health Units.NEWS5: GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture.NEWS6: GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture.NEWS7: US stock slump again after Fed raises interest rates.NEWS8: Stocks Dive After Early Rally as Fed Hikes Key Rate.NEWS9: Health Care Sector Update for 12/19/2018: GSK,PFE,FGEN,SURF.NEWS10: Health Care Sector Update for 12/19/2018: GSK,PFE,FGEN,SURF.NEWS11: US stock gains evaporate after Fed raises interest rates.NEWS12: Pfizer Inc. -- Moody's: Pfizer's JV formation with GSK is credit negative.NEWS13: GlaxoSmithKline, Pfizer Team Up to Form New Joint Venture.NEWS14: US stocks rise before Federal Reserve meeting; oil rebounds.NEWS15: Vertex Pharmaceuticals’ Gross Margin Trends.NEWS16: Understanding Vertex Pharmaceuticals’ Operational Performance.NEWS17: Dow Trades Higher as Wall Street's Got the Fed on Its Mind.NEWS18: Glaxo, Pfizer to merge consumer health care divisions.NEWS19: Glaxo, Pfizer to merge consumer health care divisions.NEWS20: GlaxoSmithKline to Break Up After Big Deal with Pfizer.NEWS21: ITOT, PFE, KO, PEP: ETF Inflow Alert.NEWS22: ITOT, PFE, KO, PEP: ETF Inflow Alert.NEWS23: GlaxoSmithKline, Pfizer To Merge Consumer Health Care Businesses.NEWS24: GlaxoSmithKline (GSK) Stock Pops on Pfizer Joint Venture.NEWS25: Glaxo to Split in Two Following Venture Deal with Pfizer.NEWS26: Glaxo, Pfizer to Merge Consumer Health Units, Form New JV.NEWS27: Glaxo, Pfizer to Merge Consumer Health Units, Form New JV.NEWS28: Pfizer Deal With Glaxo Shows Drug Giants Turning Back to the Lab.NEWS29: Big Pharma Cures Its Consumer Headache by Splitting Off Painkillers.NEWS30: Dow Rises Modestly as Wall Street's Got the Fed on Its Mind.NEWS31: Stocks - GE, General Mills Jump in Premarket; FedEx, Micron Tumble; Facebook Falls.NEWS32: Pfizer inks deal to bring Advil and Excedrin under one roof.NEWS33: [$$] Debt Is the Tonic in GSK and Pfizer's Big Deal.NEWS34: Health Care Sector Update for 12/19/2018: SURF, AVGR, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS35: Health Care Sector Update for 12/19/2018: SURF, AVGR, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS36: Stocks Open Higher: Fed Rate Hike Vote, A Dow Jones Merger.NEWS37: GSK, Pfizer create consumer health giant.NEWS38: Wall Street Sees Upbeat Open Amid Fresh Trade Optimism; Fed Decision Eyed.NEWS39: Wall Street Sees Upbeat Open Amid Fresh Trade Optimism; Fed Decision Eyed.NEWS40: Glaxo, Pfizer to Merge Consumer Health Units, Form New JV.NEWS41: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Adobe, Johnson & Johnson and IBM.NEWS42: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Adobe, Johnson & Johnson and IBM.NEWS43: US Futures in Positive Territory Amid Trade Optimism; Fed Decision Eyed.NEWS44: US Futures in Positive Territory Amid Trade Optimism; Fed Decision Eyed.NEWS45: US STOCKS-Wall Street set to open higher, Fed meeting eyed.NEWS46: Market Morning: Rate Hike Trade Guide, Mnuchin Blames HFTs, Musk Unveils Boring Hole, Facebook Claims Consent.NEWS47: Do Options Traders Know Something About Pfizer (PFE) Stock We Don't?.NEWS48: Glaxo-Pfizer Deal Creates Biggest Over-the-Counter Drug Supplier.NEWS49: Fed, Micron, Glaxo and Pfizer, FedEx and Facebook - 5 Things You Must Know.NEWS50: GSK, Pfizer to merge health care divisions.NEWS51: GSK & Pfizer to combine consumer health businesses.NEWS52: The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas.NEWS53: Pfizer consumer health deal will help fuel investments in pharma, vaccines, says GSK CEO.NEWS54: Pfizer consumer health deal will help fuel investments in pharma, vaccines, GSK CEO says.NEWS55: GSK CEO on Pfizer deal: Separation should happen within 3....NEWS56: Drugmaker GSK to split after striking Pfizer consumer health deal.NEWS57: [$$] European Equities Market Talk Roundup.NEWS58: Dow futures higher | Fed rate decision set | Pfizer, GSK agree to $12.7 billion deal.NEWS59: European Markets Climbed On Italian Budget Deal.NEWS60: European Markets Climbed On Italian Budget Deal.NEWS61: Drugmaker GSK to split after striking Pfizer consumer health deal.NEWS62: [$$] Pfizer and Glaxo to Combine Consumer-Health Businesses.NEWS63: Reckitt Can Still Make it to the Glaxo-Pfizer Party.NEWS64: Drugmaker GSK to split after striking Pfizer consumer health deal.NEWS65: GlaxoSmithKline, Pfizer Form Consumer Healthcare Group With $13 Billion in Sales.NEWS66: [$$] Glaxo, Pfizer to Combine Consumer-Health Businesses.NEWS67: [$$] GlaxoSmithKline, Pfizer to Create Consumer Healthcare JV.NEWS68: Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company.NEWS69: European Shares Rise In Cautious Trade As Italian Concerns Ease.NEWS70: European Shares Rise In Cautious Trade As Italian Concerns Ease.NEWS71: FTSE 100 Up 37 Points Ahead Of Fed Announcement.NEWS72: FTSE 100 Up 37 Points Ahead Of Fed Announcement.NEWS73: GSK, Pfizer To Combine Consumer Health Businesses Into New JV - Quick Facts.NEWS74: GSK, Pfizer To Combine Consumer Health Businesses Into New JV - Quick Facts.
2018-12-20: NEWS1: Independent Data Monitoring Committee Recommends Discontinuation of the Phase 2b STRIVE Clinical Trial of Staphylococcus aureus Vaccine Following Planned Interim Analysis.NEWS2: Commentary: GSK, Pfizer and GE shift away from diversification in latest round of health-care deals.NEWS3: British shares falter as Fed, oil play Scrooge.NEWS4: Company News For Dec 20, 2018.NEWS5: Company News For Dec 20, 2018.NEWS6: Eli Lilly and Pfizer Are Boosting Dividends.NEWS7: Health Care Sector Update for 12/20/2018: SPPI, MNKD, TLRY, BUD, PFE, JNJ, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 12/20/2018: SPPI, MNKD, TLRY, BUD, PFE, JNJ, ABT, MRK, AMGN.NEWS9: Company News For Dec 20, 2018.NEWS10: Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer.NEWS11: Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer.NEWS12: Do Analysts See Any Upside for Vertex Stock?.NEWS13: PRESS DIGEST - Wall Street Journal - Dec 20.NEWS14: Asian stocks sink after Wall Street dives on rate hike.NEWS15: [$$] Pfizer, Glaxo to Create Over-the-Counter Drug Giant.NEWS16: PRESS DIGEST- Financial Times - Dec 20.NEWS17: Exclusive: Big Pharma returning to U.S. price hikes in January after pause.NEWS18: [$$] Pfizer, Glaxo Strike Deal to Put Focus on Prescription Drugs.
2018-12-21: NEWS1: After Hours Most Active for Dec 21, 2018 :  CSCO, BAC, MSFT, XOM, AAPL, GE, PFE, QQQ, MBI, MU, KGC, FB.NEWS2: After Hours Most Active for Dec 21, 2018 :  CSCO, BAC, MSFT, XOM, AAPL, GE, PFE, QQQ, MBI, MU, KGC, FB.NEWS3: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS4: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS5: Pfizer and GlaxoSmithKline’s Joint Venture: What to Expect.NEWS6: Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study.NEWS7: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS8: Do Analysts See Any Upside for Sarepta Stock?.NEWS9: Analyzing Sarepta Therapeutics’ Gross Margin Trends.NEWS10: Taking Stock of Sarepta’s Latest Performance.NEWS11: Understanding Sarepta Therapeutics’ Operational Performance.NEWS12: Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer.NEWS13: Pfizer and GlaxoSmithKline’s Consumer Health Business.NEWS14: Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study.NEWS15: Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study.NEWS16: Pfizer and GlaxoSmithKline Form a Joint Venture.NEWS17: Former P&G manager named CEO of $12B joint venture.NEWS18: Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations.NEWS19: Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations.NEWS20: GlaxoSmithKline Capital Inc. -- Moody's affirms GSK's A2 ratings; outlook remains negative.NEWS21: Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study.NEWS22: Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations.NEWS23: The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial.NEWS24: [$$] European Equities Market Talk Roundup.NEWS25: Pfizer Discontinues Phase 2b STRIVE Clinical Trial Due To Futility.NEWS26: Pfizer Discontinues Phase 2b STRIVE Clinical Trial Due To Futility.
2018-12-24: NEWS1: After Hours Most Active for Dec 24, 2018 :  S, QQQ, SQQQ, KGC, PLNT, PFE, BAC, MU, QSR, INTC, IEF, SLM.NEWS2: After Hours Most Active for Dec 24, 2018 :  S, QQQ, SQQQ, KGC, PLNT, PFE, BAC, MU, QSR, INTC, IEF, SLM.NEWS3: How Pfizer’s Sutent and Xalkori Have Performed.NEWS4: This Drug Is Expected to Be a Significant Driver for Pfizer.NEWS5: How Pfizer’s Oncology Business Is Positioned.NEWS6: Health Care Sector Update for 12/24/2018: ACOR, CDXC, RDY, JNJ, PFE, MRK, ABT, AMGN.NEWS7: Health Care Sector Update for 12/24/2018: ACOR, CDXC, RDY, JNJ, PFE, MRK, ABT, AMGN.NEWS8: Pfizer/Merck KGaA End Bavencio Ovarian Cancer Phase III Study.NEWS9: Pfizer Falls 3%.
2018-12-26: NEWS1: How to Save $650 Million Without Really Trying.NEWS2: How to Save $650 Million Without Really Trying.NEWS3: Pfizer Rises 3%.NEWS4: Here Are The 5 Best Dividend Stocks On The Dow Jones Average By Yield.NEWS5: How to Save $650 Million Without Really Trying.NEWS6: Should You Buy PFE Stock on Pfizer’s Joint Venture With Glaxo?.NEWS7: Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?.NEWS8: Bristol-Myers Squibb Stock Is Coming Back Slow, but That’s Fine.NEWS9: Pfizer’s Prevnar 13 and Other Developments.

Answer: Rise